After blocking CD200, initially arthritis-resistant animals developed joint inflammation on day 21 (Fig. 4l), supporting the critical gate-keeping role of CD200+ fibroblasts interacting with migrating CD2+MHC-II+CCR2+ myeloid precursors. This evidence concerns the gene CD200 and arthritic joint disease.